Biological Products

Malattia di Behçet: una sfida per il pediatra

Levantino L, Pastore S, Corona F, Lepore L, Tommasini L.

2022/5 — pag. 289-297 — DOI

Behçet’s disease (BD) is a rare chronic inflammatory condition associated with variable-vessel vasculitis, systemic involvement and relapsing course. It is characterized by a wide clinical heterogeneity, presenting with mucocutaneous, ocular, articul...

Artrite idiopatica giovanile

L. Lepore, S. Pastore, A. Taddio

2020/6 — pag. 357-364

Juvenile idiopathic arthritis is the most frequent rheumatic disease in childhood. Its diagnosis is still clinical and recently new classification criteria have been proposed. Over the past twenty years, there have been significant improvement in u...

Tempi di... reflusso per i PPI Metilfenidato e ADHD Dolce dormire per prevenire l’obesità Celiachia senza biopsia Effetti (benefici) a lungo termine dello screening uditivo neonatale Terapia biologica per la dermatite atopica “intrattabile”

2016/1 — pag. 9-10

I farmaci biosimilari

A. Genazzani

2015/6 — pag. 386-388

The physico-chemical properties of biotechnological drugs are tightly linked to their manufacturing process. Yet, pharmaceutical companies that wish to make important manufacturing changes to their process may do so as long as they follow ICHQ5E gu...

Gli inibitori del TNF alfa nella cura delle malattie infiammatorie croniche: luci e ombre

G. Gortani, S. Martelossi, L. Lepore

2012/5 — pag. 314-321

The present article descibes the use of TNF inhibitors in paediatrics, with special focus on etanercept, infliximab and adalimumab. Their molecular structure and mechanism of action are accurately described. Licensed and sperimental applications ar...

Le spondiloartropatie in età pediatrica

A. Lenhardt e collaboratori

2006/7 — pag. 429-437

Spondyloarthropathies are a heterogeneous group of morbid conditions, characterized by familiarity, by their association with specific HLA and by extra-articular localisations. In the present article the different morbid conditions, their most recent...

Nuovi farmaci per l'artrite reumatoide (parte seconda)

G. Bartolozzi

2004/7